How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician

Managing inflammatory bowel disease (IBD) during the coronavirus disease 2019 (COVID-19) pandemic has been a challenge faced by clinicians and their patients, especially concerning whether to proceed with biologics and immunosuppressive agents in the background of a global outbreak of a highly conta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of gastroenterology : WJG 2021-03, Vol.27 (11), p.1022-1042
Hauptverfasser:	Chebli, Júlio Maria Fonseca, Queiroz, Natália Sousa Freitas, Damião, Adérson Omar Mourão Cintra, Chebli, Liliana Andrade, Costa, Márcia Henriques de Magalhães, Parra, Rogério Serafim
Format:	Artikel
Sprache:	eng
Schlagworte:	Ambulatory Care Biological Products - therapeutic use Carrier State COVID-19 - complications Deprescriptions Disease Management Endoscopy, Gastrointestinal Glucocorticoids - therapeutic use Hospitalization Humans Immunologic Factors - therapeutic use Immunosuppressive Agents - therapeutic use Inflammatory Bowel Diseases - complications Inflammatory Bowel Diseases - drug therapy Practice Guidelines as Topic Review Risk Factors SARS-CoV-2 Severity of Illness Index Telemedicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!